MediPharm Labs Corp. (TSX:LABS)

Revenue by Segment

Financials in millions CAD. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Production and Sales Of Cannabis Flower, Extracts and Derivative Products	45.12M	41.96M	33.06M	22.12M	21.71M
Production and Sales Of Cannabis Flower, Extracts and Derivative Products Growth	7.54%	26.92%	49.49%	1.87%	-39.71%
Total	45.12M	41.96M	33.06M	22.12M	21.71M
Total Growth	7.54%	26.92%	49.49%	1.87%	-39.71%

Revenue by Geography

Financials in millions CAD. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Canada	19.76M	24.15M	23.09M	14.69M	12.22M
Canada Growth	-18.16%	4.60%	57.17%	20.25%	-61.50%
Australia	10.72M	8.83M	5.39M	2.61M	4.30M
Australia Growth	21.33%	63.91%	106.63%	-39.35%	0.28%
Germany	12.01M	8.58M	3.58M	3.65M	5.15M
Germany Growth	40.01%	139.39%	-1.89%	-29.16%	-
Other	2.64M	407.00K	1.01M	1.17M	42.00K
Other Growth	548.65%	-59.54%	-14.02%	2685.71%	-
Total	45.12M	41.96M	33.06M	22.12M	21.71M
Total Growth	7.54%	26.92%	49.49%	1.87%	-39.71%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jun 8, 2026

Data Sources Report a data error